“Plaque” on a brain MRI almost always refers to a bright spot visible on certain scan sequences, most commonly a white matter hyperintensity (WMH) or, in the context of multiple sclerosis, a demyelinating lesion. These findings range from clinically meaningless age-related changes to early markers of serious neurological disease, depending on their size, number, location, and the person’s medical history. The term can alarm patients who associate “plaque” with Alzheimer’s amyloid deposits, but standard MRI cannot image amyloid plaques directly. What your radiologist is flagging is something different, and understanding the distinction matters for every conversation that follows.
Why Radiologists Call Them “Plaques”
The word “plaque” in neuroradiology is borrowed from older French medical usage meaning a patch or flat area. On a brain MRI, it describes a focal area that lights up brighter than surrounding tissue on T2-weighted or FLAIR sequences. These bright spots reflect increased water content in the tissue, which can result from demyelination (loss of the insulating sheath around nerve fibers), gliosis (scarring by support cells), inflammation, or tiny areas of tissue damage from impaired blood flow. Despite decades of study, the exact mix of pathology underlying any individual bright spot remains surprisingly hard to pin down without examining the tissue directly.
White matter hyperintensities of presumed vascular origin are the most common type. They appear on nearly every MRI of an older adult to some degree. Their discovery dates back to the early days of CT scanning, yet their precise histopathology is still debated, which has slowed the development of targeted treatments.1PubMed Central. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment When a radiologist writes “plaque” or “plaques” on your report, they are describing what they see on the image. What it means for your health depends on the clinical context your neurologist brings to the table.
Age-Related White Matter Changes
Some degree of white matter hyperintensity is nearly universal in people over 60. Small, scattered bright spots in the deep white matter are so common in older adults that many neuroradiologists consider a modest burden of them a normal feature of brain aging rather than a disease marker. In a large population-based study, the prevalence of asymptomatic brain infarcts and white matter lesion volume both increased steadily with age.2PubMed. Incidental findings on brain MRI in the general population
The challenge is distinguishing “normal aging” from early pathology. Research comparing the tissue properties of white matter hyperintensities with the surrounding normal-appearing white matter found that the lesions show clear structural differences, with significant reductions in fiber integrity inside the bright spots.3PubMed Central. White matter hyperintensities and normal-appearing white matter integrity in the aging brain Even more concerning, studies of very old adults show that the normal-looking white matter immediately surrounding a hyperintensity also harbors damage, including demyelination, activated immune cells, and disrupted water-channel proteins, with severity trailing off the farther you get from the lesion.4PubMed Central. White matter hyperintensities and the surrounding normal appearing white matter are associated with water channel disruption in the oldest old In other words, the visible bright spot on MRI may represent only the core of a wider zone of tissue compromise.
So when do age-related white matter changes cross the line into something clinically worrying? Volume matters. People with cognitive impairment consistently have larger total volumes of white matter hyperintensities than cognitively healthy peers, and groups with vascular contributions to their cognitive problems carry the highest burdens.5PubMed Central. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts A handful of tiny dots scattered through the deep white matter in a 70-year-old is a very different finding from confluent sheets of signal change spreading out from the ventricles.
Multiple Sclerosis Lesions
In younger adults, the word “plaque” on a brain MRI often raises the question of multiple sclerosis. MS plaques are demyelinating lesions where the immune system has attacked the myelin sheath around nerve fibers, leaving behind areas of inflammation and scarring that show up as bright spots. Typical MS lesions are round to oval, range from a few millimeters to more than a centimeter across, and generally need to be at least 3 mm on their long axis to satisfy diagnostic criteria.6PubMed Central. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
Location is a major clue. MS lesions favor certain spots: the periventricular white matter (around the fluid-filled cavities deep in the brain), the corpus callosum (the bridge connecting the two hemispheres), the brainstem, the cerebellum, and the spinal cord. They also appear in the cortex itself, where research using ultra-high-field MRI has identified several subtypes, including lesions that cross from white matter into gray matter and subpial lesions that can stretch across entire brain folds.7JAMA Neurology. Imaging Cortical Lesions in Multiple Sclerosis With Ultra–High-Field Magnetic Resonance Imaging The pattern of lesion distribution, not just the presence of bright spots, is what helps neurologists distinguish MS from the many other causes of white matter hyperintensities.
A related but distinct condition, neuromyelitis optica spectrum disorder (NMOSD), produces lesions that can look similar to MS on MRI but follow a different pattern and respond to different treatments. NMOSD is driven by antibodies that target a specific water channel protein on astrocytes, and the lesions tend to favor the optic nerves and spinal cord rather than the periventricular white matter typical of MS.8PubMed Central. A case of neuromyelitis optica spectrum disorder with coexisting systemic lupus erythematosus Telling these conditions apart early matters because the wrong treatment can make NMOSD worse.
Cerebral Small Vessel Disease
Many white matter hyperintensities in middle-aged and older adults arise from damage to the brain’s tiny blood vessels, a condition called cerebral small vessel disease. This is not one single disorder but a family of problems affecting the smallest arteries, arterioles, and capillaries that supply the deep brain tissue. The resulting cascade includes blood-brain barrier dysfunction, impaired blood flow regulation, vessel stiffening, inflammation, myelin damage, and eventually neurodegeneration.9PubMed. Small vessel disease: mechanisms and clinical implications
High blood pressure is the single biggest modifiable driver of this process. Years of elevated pressure damage the walls of these tiny vessels, which gradually lose their ability to regulate blood flow to the surrounding tissue. The white matter, which depends on a relatively sparse blood supply to begin with, is especially vulnerable. The bright spots that accumulate on MRI over time represent zones where this chronic under-perfusion has caused tissue injury.
Besides white matter hyperintensities, small vessel disease can also produce lacunar infarcts (tiny strokes visible as small dark holes on certain sequences), cerebral microbleeds, and enlarged perivascular spaces. Radiologists increasingly report all of these features together because their combined burden tells a more complete story about vascular brain health than any single finding alone.
What Brain Plaques Mean for Dementia Risk
A key concern for many patients is whether the plaques on their MRI predict cognitive decline. The short answer is that higher volumes of white matter hyperintensities are consistently associated with a greater risk of developing dementia, especially vascular dementia. A systematic review and meta-analysis found that all patients in the vascular dementia group had high white matter signals on MRI and significantly greater WMH volumes compared to people with normal cognition, mild cognitive impairment, or even Alzheimer’s disease alone.10PubMed Central. White matter hyperintensities and the risk of vascular dementia: a systematic review and meta-analysis Irregular, periventricular hyperintensities were the most specific to vascular dementia.
In a large population-based study with an average follow-up of about five years, higher severity of periventricular white matter lesions increased dementia risk with an adjusted hazard ratio of roughly 1.7 for each standard-deviation increase in lesion severity. That association held even after controlling for other known dementia risk factors.11Archives of Neurology. Cerebral White Matter Lesions and the Risk of Dementia Subcortical lesions showed a weaker link.
A major meta-analysis confirmed that white matter hyperintensities were associated with increased dementia risk in the general population, though the picture was more complex in people already classified as high-risk, such as those with mild cognitive impairment or prior stroke. When researchers broke dementia into subtypes, the strongest link was with vascular dementia. The connection to Alzheimer’s disease was driven by large population studies and was less consistent in smaller, higher-risk groups.12BMJ. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis
Combining MRI findings with blood biomarkers may sharpen the picture further. Research pairing white matter hyperintensity volume with neurofilament light chain (a blood marker of nerve fiber damage) found that both were similarly linked to the rate of cognitive decline, but appeared to reflect different underlying mechanisms.13PubMed Central. White matter hyperintensity, neurofilament light chain, and cognitive decline In practice, this means your doctor may eventually use a combination of imaging and a simple blood test to estimate your trajectory more precisely than either measure alone.
Silent Brain Infarcts and Future Stroke
Some bright spots on MRI are not diffuse white matter changes but small, silent strokes that happened without any obvious symptoms. These silent brain infarcts are common: in one large cohort, about 28% of participants had evidence of at least one, and the rate of future clinically apparent stroke was roughly twice as high in those with silent infarcts compared to those without them.14PubMed. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study People with multiple silent infarcts faced an even steeper increase in risk.
A systematic review pooling data from studies involving thousands of stroke-free individuals confirmed these findings, reporting that silent brain infarcts roughly doubled the risk of future stroke even after adjusting for conventional cardiovascular risk factors like hypertension and diabetes.15PubMed Central. Silent Brain Infarction and Risk of Future Stroke: A Systematic Review and Meta-Analysis This makes silent infarcts one of the more actionable findings on a brain MRI, because identifying them can prompt aggressive management of blood pressure, cholesterol, and other vascular risk factors before a disabling stroke occurs.
Migraine-Related Brain Changes
If you have migraines and your MRI shows a few small white matter hyperintensities, the natural reaction is worry. Migraine sufferers do tend to have more of these bright spots than the general population. A study of 186 migraine patients found that longer disease duration and higher attack frequency were both significantly associated with the presence of white matter hyperintensities, along with comorbid conditions like elevated homocysteine levels.16PubMed Central. Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients
However, a separate study focusing specifically on young migraine patients without vascular risk factors painted a more reassuring picture. In these patients, the hyperintensities were typically rare, small (around 2.5 mm), and located in the frontal, parietal, and temporal lobes. There was no association between these spots and migraine subtype, attack severity, or the development of vascular complications, leading the researchers to conclude that these white matter changes carry very low prognostic value for migraine outcomes.17Scientific Reports. White matter hyperintensity in different migraine subtypes The practical takeaway: a few tiny bright spots in a young migraine patient without hypertension or diabetes are usually not a cause for alarm, though they often generate unnecessary anxiety.
Hereditary Conditions That Mimic Common Small Vessel Disease
Occasionally, a pattern of white matter hyperintensities on MRI points to a genetic disorder rather than ordinary aging or hypertension. The most well-known is CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), caused by mutations in the NOTCH3 gene. MRI in CADASIL shows white matter hyperintensities, lacunar infarcts, and microbleeds, but with a distribution pattern distinct from typical small vessel disease: the lesions tend to be symmetrical and bilateral, and they favor the anterior temporal lobes and external capsules with high specificity.18PubMed Central. Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL)
In one study of 68 CADASIL patients, 90% had white matter hyperintensities, most prominently around the ventricles and in deep white matter. Roughly 60% also had changes in the basal ganglia and 45% in the brainstem. In about a third of patients, the hyperintensities appeared without accompanying small deep infarcts, which can make early CADASIL look deceptively like ordinary age-related changes on a quick read.19PubMed. Patterns of MRI lesions in CADASIL The anterior temporal lobe involvement is the red flag that should trigger genetic testing, especially in younger patients with a family history of early stroke or dementia.20PubMed. Cerebral hemodynamics and white matter hyperintensities in CADASIL
Traumatic Brain Injury and Diffuse Axonal Injury
After head trauma, MRI can reveal a different kind of brain lesion. Diffuse axonal injury occurs when rotational forces during an accident shear nerve fibers, especially at junctions between tissues of different density like the gray-white matter boundary. These injuries show up as scattered tiny dark spots on susceptibility-weighted imaging (indicating microscopic bleeding) and as areas of reduced fiber integrity on diffusion-based sequences. In one case study using advanced MRI, hemorrhagic foci appeared at the gray-white matter junction of both frontal and temporal lobes, as well as in deep structures like the corpus callosum and fornix, with diffusion tractography confirming disrupted white matter fibers.21PubMed Central. Diffuse axonal injury: a case report and MRI findings
These post-traumatic lesions look different from the bright periventricular spots of small vessel disease or the oval lesions of MS, so an experienced radiologist can usually tell them apart. But in patients with a remote history of head injury who present years later with cognitive problems, the old injury sites may have evolved into nonspecific white matter changes that require careful correlation with the clinical history.
Incidental Findings and When to Worry
Many brain MRIs are ordered for reasons unrelated to white matter disease, such as investigating headaches, dizziness, or hearing loss, and the bright spots show up as incidental findings. In a large population-based study, more than 3% of middle-aged and elderly people had incidental findings on brain MRI that warranted referral to a specialist. But of those referred, over three-quarters either required no treatment or were simply monitored, and the majority of untreated findings remained stable over follow-up lasting up to nine years.22PubMed. Prevalence, Clinical Management, and Natural Course of Incidental Findings on Brain MR Images: The Population-based Rotterdam Scan Study
The psychological dimension is real but under-discussed. Research on patients who received unexpected news about incidental brain findings showed that most preferred to hear the results in person rather than over the phone, and satisfaction with how the news was delivered varied widely.23PubMed Central. Patients’ anxiety around incidental brain tumors: a qualitative study The chance of an incidental finding turning out to be a malignant brain tumor is less than 0.1% in the general population. Knowing that number before the scan might spare some patients weeks of dread while waiting for a follow-up appointment.
Can You Slow the Progression?
Because hypertension is the dominant modifiable driver of white matter hyperintensities, blood pressure control is the most evidence-backed way to slow their accumulation. A meta-analysis of randomized trials found that intensive blood pressure control significantly slowed WMH progression, and the benefit was proportional to the degree of pressure reduction.24PubMed Central. Effect of intensive blood pressure control on the prevention of white matter hyperintensity: Systematic review and meta-analysis of randomized trials
The landmark SPRINT MIND trial provided direct evidence. Among hypertensive adults, targeting a systolic blood pressure below 120 mm Hg rather than below 140 mm Hg resulted in a significantly smaller increase in white matter lesion volume over follow-up. The intensive-treatment group saw their lesion volume rise less than the standard-treatment group by about half a cubic centimeter, a modest but statistically meaningful difference.25JAMA. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions One important caveat: intensive blood pressure lowering was also associated with slightly greater total brain volume loss, which suggests the relationship between aggressive treatment and brain health is not entirely straightforward. Still, for most people with hypertension, getting blood pressure under control is the clearest thing you can do about those bright spots.
Tracking Changes Over Time
A single MRI snapshot can tell you what lesions are present, but serial imaging over months or years reveals something more valuable: whether the disease is progressing, stable, or responding to treatment. This is especially critical in MS, where chronic white matter lesion activity measured by slowly expanding lesions on repeat scans predicted subsequent disability progression, and treatment with disease-modifying therapies reduced that activity.26Brain. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis
Getting reliable longitudinal measurements is harder than it sounds. Differences in scanner hardware, software versions, and patient positioning between visits can introduce noise that masks or mimics real changes. Expert consensus recommendations have pushed for standardized protocols and analysis pipelines to improve accuracy.27PubMed Central. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis Newer automated segmentation tools that use deep learning can now track subtle morphological changes across dozens of brain structures while maintaining consistency between time points.28PubMed Central. An open-source tool for longitudinal whole-brain and white matter lesion segmentation For patients being monitored for MS or vascular disease progression, these advances mean earlier detection of worsening and more confident decisions about when to escalate treatment.
Amyloid Plaques and Why Standard MRI Cannot See Them
One of the biggest sources of confusion is the assumption that “plaque on brain MRI” refers to the amyloid plaques of Alzheimer’s disease. It almost never does. Amyloid-beta deposits are microscopic protein aggregates that accumulate between neurons, and they are far too small to generate signal on a standard clinical MRI. Detecting amyloid requires either a PET scan using a specialized radiotracer or, increasingly, cerebrospinal fluid or blood biomarker tests. Research combining PET with MRI in animal models has shown that hybrid imaging can detect amyloid deposits with high spatial resolution, but this technology remains a research tool and is not part of routine clinical scanning.29Nature. Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer’s disease mouse model
That said, the white matter hyperintensities visible on standard MRI do overlap with Alzheimer’s risk. People who go on to develop Alzheimer’s tend to have higher burdens of white matter lesions than age-matched controls, though whether the lesions are contributing to the dementia or are just fellow travelers of the same vascular risk factors remains an open question. If your doctor suspects Alzheimer’s, the MRI is one piece of the puzzle, useful for ruling out other causes and assessing vascular burden, but it cannot confirm or deny the presence of amyloid on its own.